Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suicidality in Body Dysmorphic Disorder.

Katharine A Phillips1

  • 1Dr. Phillips is professor of psychiatry and human behavior at the Warren Alpert Medical School of Brown University and director of the Body Dysmorphic Disorder and Body Image Program at Butler Hospital in Providence, Rhode Island.

Primary Psychiatry
|May 2, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Population-Based Family Clustering Study of Body Dysmorphic Disorder.

Biological psychiatry·2026
Same author

Question: What Is Olfactory Reference Disorder, and How Should We Treat It?

Journal of clinical psychopharmacology·2025
Same author

Empirically informed symptom severity cutoffs for body dysmorphic disorder.

Journal of psychiatric research·2025
Same author

Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder: Factor Structure and Construct Validity of Subfactors.

Journal of obsessive-compulsive and related disorders·2025
Same author

Question: What Are the Latest Guidelines for Treating Individuals With Body Dysmorphic Disorder?

Journal of clinical psychopharmacology·2024
Same author

The efficacy of psychological treatments on body dysmorphic disorder: a meta-analysis and trial sequential analysis of randomized controlled trials.

Psychological medicine·2024
Same journal

The Utility of a Connecting Framework to Facilitate Understanding of and Reduce the Disparities in Hospice Care Experienced by Racial and Ethnic Minorities.

Primary psychiatry·2017
Same journal

Biologic Commonalities between Mental Illness and Addiction.

Primary psychiatry·2015
Same journal

IMAGING THE BRAIN AS SCHIZOPHRENIA DEVELOPS: DYNAMIC & GENETIC BRAIN MAPS.

Primary psychiatry·2011
Same journal

Effects of Δ-THC on Working Memory: Implications for Schizophrenia?

Primary psychiatry·2011
Same journal

Ethnic Differences in Suicidal Ideation and Attempts.

Primary psychiatry·2010
Same journal

Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable?

Primary psychiatry·2009
See all related articles

Body dysmorphic disorder (BDD) is linked to high rates of suicidal thoughts and attempts. Early recognition and effective treatments like cognitive-behavioral therapy and SRIs are crucial for managing BDD and reducing suicide risk.

Area of Science:

  • Psychiatry
  • Psychology
  • Public Health

Background:

  • Body dysmorphic disorder (BDD) is a prevalent condition often associated with significant suicidality.
  • High lifetime prevalence of suicidal ideation (80%) and suicide attempts (24-28%) is reported in BDD patients.
  • Completed suicide rates in BDD are preliminarily indicated as markedly high.

Purpose of the Study:

  • To review existing evidence on suicidality in BDD.
  • To discuss the recognition, diagnosis, and treatment of BDD.
  • To highlight the need for further research into BDD-related suicidality.

Main Methods:

  • Literature review of available evidence on suicidality in BDD.
  • Discussion of diagnostic criteria and clinical presentation of BDD.

Related Experiment Videos

  • Overview of current treatment modalities for BDD.
  • Main Results:

    • BDD is underrecognized despite its prevalence and association with severe suicidality.
    • Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral therapy are effective BDD treatments.
    • SRIs may reduce suicidality in individuals with BDD.

    Conclusions:

    • Recognizing and treating BDD is critical due to its high suicide risk.
    • Further research is essential to understand and prevent suicidality in BDD.
    • Integrated treatment approaches are needed for BDD and associated suicidality.